These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29316712)

  • 21. Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.
    Roxo-Rosa M; Xu Z; Schmidt A; Neto M; Cai Z; Soares CM; Sheppard DN; Amaral MD
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17891-6. PubMed ID: 17098864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids.
    Lim M; McKenzie K; Floyd AD; Kwon E; Zeitlin PL
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):351-7. PubMed ID: 15191910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new 9-alkyladenine-cyclic methylglyoxal diadduct activates wt- and F508del-cystic fibrosis transmembrane conductance regulator (CFTR) in vitro and in vivo.
    Boucherle B; Bertrand J; Maurin B; Renard BL; Fortuné A; Tremblier B; Becq F; Norez C; Décout JL
    Eur J Med Chem; 2014 Aug; 83():455-65. PubMed ID: 24992073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
    deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
    Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel pharmacological strategies to treat cystic fibrosis.
    Hanrahan JW; Sampson HM; Thomas DY
    Trends Pharmacol Sci; 2013 Feb; 34(2):119-25. PubMed ID: 23380248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of molecular determinants that modulate trafficking of DeltaF508 CFTR, the mutant ABC transporter associated with cystic fibrosis.
    Tsigelny I; Hotchko M; Yuan JX; Keller SH
    Cell Biochem Biophys; 2005; 42(1):41-53. PubMed ID: 15673927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correctors enhance maturation of DeltaF508 CFTR by promoting interactions between the two halves of the molecule.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2009 Oct; 48(41):9882-90. PubMed ID: 19761259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.
    Namkung W; Kim KH; Lee MG
    Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Processing and function of CFTR-DeltaF508 are species-dependent.
    Ostedgaard LS; Rogers CS; Dong Q; Randak CO; Vermeer DW; Rokhlina T; Karp PH; Welsh MJ
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15370-5. PubMed ID: 17873061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
    Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
    J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rescue of DeltaF508 and other misprocessed CFTR mutants by a novel quinazoline compound.
    Loo TW; Bartlett MC; Clarke DM
    Mol Pharm; 2005; 2(5):407-13. PubMed ID: 16196493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ΔF508-CFTR correctors: synthesis and evaluation of thiazole-tethered imidazolones, oxazoles, oxadiazoles, and thiadiazoles.
    Ye L; Hu B; El-Badri F; Hudson BM; Phuan PW; Verkman AS; Tantillo DJ; Kurth MJ
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5840-5844. PubMed ID: 25452003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and characterization of synthetic antibodies binding to the cystic fibrosis conductance regulator.
    Gakhal AK; Jensen TJ; Bozoky Z; Roldan A; Lukacs GL; Forman-Kay J; Riordan JR; Sidhu SS
    MAbs; 2016; 8(6):1167-76. PubMed ID: 27185291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional cystic fibrosis transmembrane conductance regulator tagged with an epitope of the vesicular stomatis virus glycoprotein can be addressed to the apical domain of polarized cells.
    Costa de Beauregard MA; Edelman A; Chesnoy-Marchais D; Tondelier D; Lapillonne A; El Marjou F; Robine S; Louvard D
    Eur J Cell Biol; 2000 Nov; 79(11):795-802. PubMed ID: 11139142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Click-based synthesis of triazolobithiazole ΔF508-CFTR correctors for cystic fibrosis.
    Donald MB; Rodriguez KX; Shay H; Phuan PW; Verkman AS; Kurth MJ
    Bioorg Med Chem; 2012 Sep; 20(17):5247-53. PubMed ID: 22841006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomechanics combined with HDX reveals allosteric drug binding sites of CFTR NBD1.
    Padányi R; Farkas B; Tordai H; Kiss B; Grubmüller H; Soya N; Lukács GL; Kellermayer M; Hegedűs T
    Comput Struct Biotechnol J; 2022; 20():2587-2599. PubMed ID: 35685375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemically modified peptide scaffolds target the CFTR-associated ligand PDZ domain.
    Amacher JF; Zhao R; Spaller MR; Madden DR
    PLoS One; 2014; 9(8):e103650. PubMed ID: 25136860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent s-cis-locked bithiazole correctors of DeltaF508 cystic fibrosis transmembrane conductance regulator cellular processing for cystic fibrosis therapy.
    Yu GJ; Yoo CL; Yang B; Lodewyk MW; Meng L; El-Idreesy TT; Fettinger JC; Tantillo DJ; Verkman AS; Kurth MJ
    J Med Chem; 2008 Oct; 51(19):6044-54. PubMed ID: 18788728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational Coupled Dynamics Network Manipulation Rescues Disease-Relevant Mutant Cystic Fibrosis Transmembrane Conductance Regulator.
    Proctor EA; Kota P; Aleksandrov AA; He L; Riordan JR; Dokholyan NV
    Chem Sci; 2015 Feb; 6(2):1237-1246. PubMed ID: 25685315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational Analysis of Energy Landscapes Reveals Dynamic Features That Contribute to Binding of Inhibitors to CFTR-Associated Ligand.
    Holt GT; Jou JD; Gill NP; Lowegard AU; Martin JW; Madden DR; Donald BR
    J Phys Chem B; 2019 Dec; 123(49):10441-10455. PubMed ID: 31697075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.